The degradation of nature and rising temperatures threaten the effectiveness of health inputs and the availability of active ingredients to fight these diseases.
The supply of drugs and technologies that play a crucial role in fighting HIV-AIDS, tuberculosis and malaria is at risk from the effects of climate change, according to UNITAID, which promotes access to disease treatment in developing countries.
Five drugs, various types of diagnostics and technologies such as mosquito nets and medical oxygen production facilities play a crucial role.
The report, published just days before the COP28 climate change meeting in Dubai, noted that the healthcare sector contributes to 4.6% of global greenhouse emissions annually.
The financial mechanism called on industry, governments and pharmaceuticals to act now before it is too late, in order to guarantee product availability and reduce their carbon footprint.
Established in 2006, UNITAID is an international drug-buying entity that raises funds through a combination of air transport taxes and long-term public funding.